Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> D >> (4alpha,12beta)-9,12-Dihydroxy-15-oxokauran-18-oic acid

(4alpha,12beta)-9,12-Dihydroxy-15-oxokauran-18-oic acid
[CAS# 1401419-89-3]

List of Suppliers
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
BioBioPha Co., Ltd. China Inquire  
+86 (871) 6521-7109
sales@mail.biobiopha.com
QQ chat
Chemical manufacturer
chemBlink standard supplier since 2011
Complete supplier list of (4alpha,12beta)-9,12-Dihydroxy-15-oxokauran-18-oic acid
Identification
Classification Natural product >> Terpenes
Name (4alpha,12beta)-9,12-Dihydroxy-15-oxokauran-18-oic acid
Molecular Structure CAS # 1401419-89-3, (4alpha,12beta)-9,12-Dihydroxy-15-oxokauran-18-oic acid
Molecular Formula C20H30O5
Molecular Weight 350.45
CAS Registry Number 1401419-89-3
Properties
Solubility Slightly soluble (4.6 g/L) (25 ºC), Calc.*
Density 1.28±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2014 ACD/Labs)
Market Analysis Reports
List of Reports Available for (4alpha,12beta)-9,12-Dihydroxy-15-oxokauran-18-oic acid
Related Products
(3beta,4alpha,20beta)-3,23-Dihydroxyolean-12-ene-28,29-dioic acid 28-ethyl 29-methyl ester  (3beta,4beta,19alpha)-3,19-Dihydroxy-olean-12-ene-23,28-dioic acid 28-beta-D-glucopyranosyl ester  3,22-Dihydroxyolean-12-en-29-oic acid  2,3-Dihydroxy-12-oleanen-28-oic acid  1-[(4R,5R)-4,5-Dihydroxy-L-ornithine]echinocandin B  1-[(4R,5R)-4,5-Dihydroxy-L-ornithine]echinocandin B hydrochloride (1:1)  (11beta,17alpha)-11,17-Dihydroxy-3-oxoandrosta-1,4-diene-17-carboxylic acid  (3alpha,5beta,12alpha)-3,12-Dihydroxy-7-oxocholan-24-oic acid methyl ester  2-[[(3alpha,5beta,12alpha)-3,12-Dihydroxy-24-oxocholan-24-yl]amino]-ethanesulfonic acid monosodium salt hydrate  (4alpha,6alpha)-6,13-Dihydroxy-15-oxokaura-9(11),16-dien-18-oic acid  (4alpha,6beta)-6,9-Dihydroxy-15-oxokauran-18-oic acid  [1(Z,Z),6(2alpha,3beta,4beta)]-(4R,5R)-4,5-Dihydroxy-N2-(1-oxo-9,12-octadecadienyl)-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(4-hydroxyphenyl)-L-threonyl-L-threonyl-3-hydroxy-4-methyl-L-proline cyclic (6→1)-peptide  3,5-Dihydroxy-2-(1-oxooctyl)benzeneacetic acid ethyl ester  (11β,17E)-11,20-Dihydroxy-3-oxopregna-4,17-dien-21-al  (11β,17Z)-11,20-Dihydroxy-3-oxo-pregna-4,17(20)-dien-21-al  (5Z,8xi,12xi,13E)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid  1-[[[3,11-Dihydroxy-3'-oxospiro[7H-dibenzo[c,h]xanthene-7,1'(3'H)-isobenzofuran]-5'(or 6')-yl]carbonyl]oxy]-2,5-pyrrolidinedione  N,N'-[(3',6'-Dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-4',5'-diyl)bis(methylene)]bis[N-(2-ethoxy-2-oxoethyl)-glycine] 1,1'-diethyl ester  N-[[[3',6'-Dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5(or 6)-yl]amino]thioxomethyl]-beta-alanyl-L-alpha-aspartyl-L-alanyl-L-alpha-glutamyl-L-phenylalanyl-L-arginyl-L-histidyl-L-alpha-aspartyl-L-serylglycyl-L-tyrosyl-L-alpha-glutamyl-L-valyl-L-histidyl-L-histidyl-L-glutaminyl-L-lysyl-L-leucyl-L-valyl-L-phenylalanyl-L-phenylalanyl-L-alanyl-L-alpha-glutamyl-L-alpha-aspartyl-L-valylglycyl-L-seryl-L-asparaginyl-L-lysylglycyl-L-alanyl-L-isoleucyl-L-isoleucylglycyl-L-leucyl-L-methionyl-L-valylglycylglycyl-L-valyl-L-valine  N-[[[3',6'-Dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5(or 6)-yl]amino]thioxomethyl]-beta-alanyl-L-alpha-aspartyl-L-alanyl-L-alpha-glutamyl-L-phenylalanyl-L-arginyl-L-histidyl-L-alpha-aspartyl-L-serylglycyl-L-tyrosyl-L-alpha-glutamyl-L-valyl-L-histidyl-L-histidyl-L-glutaminyl-L-lysyl-L-leucyl-L-valyl-L-phenylalanyl-L-phenylalanyl-L-alanyl-L-alpha-glutamyl-L-alpha-aspartyl-L-valylglycyl-L-seryl-L-asparaginyl-L-lysylglycyl-L-alanyl-L-isoleucyl-L-isoleucylglycyl-L-leucyl-L-methionyl-L-valylglycylglycyl-L-valyl-L-valyl-L-isoleucyl-L-alanine